Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors

Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors

US Patent 11446289 · Granted Sep 20, 2022

Estimated economic value: $141,892,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Azetidinyl-acetamides as CXCR7 inhibitors2025
Floating chair2025
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases2025
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases2025
Cyclic compounds as receptor modulating therapeutics and methods and uses thereo2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors2025
TGF-β inhibitors2025
Method of treating focal segmental glomerulosclerosis2025